search
Back to results

Cook Venous Valve System for Treatment of Chronic Venous Insufficiency

Primary Purpose

Venous Insufficiency of Leg

Status
Recruiting
Phase
Not Applicable
Locations
Colombia
Study Type
Interventional
Intervention
Cook® Venous Valve System
Sponsored by
MED Institute Inc.
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Venous Insufficiency of Leg

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Limited inclusion criteria: Documented symptomatic deep venous reflux in one limb Deep venous reflux in the region of interest Limited exclusion criteria: General: Age < 18 years BMI ≥ 40 Cultural objections to porcine materials Unwillingness or inability to comply with the follow-up Unwillingness to provide study data for duration of study Simultaneous participation in another device or drug study Inability or refusal to give informed consent Medical: Pregnant, or planning to become pregnant Diagnosis of terminal illness with life expectancy less than 12 months Complete symptom resolution with compliant compression therapy for three months Untreated superficial venous disease Medical interventions including any of the following: planned procedure of any leg, vascular intervention or major surgery within the last three months, implanted inferior vena cava filter Medical history of any of the following: anticoagulation treatment for pulmonary embolism (within the last six months or ongoing), insulin dependent diabetes, chronic obstructive pulmonary disease, renal dysfunction requiring dialysis, leg amputation, bleeding diathesis, untreated or unresolved systemic infection or local infection, active malignancy except non-melanoma skin cancer, other acute or chronic medical condition that may cause noncompliance with the protocol or confound the study results, documented history of significant untreated stenosis within the arterial system Positive coronavirus (COVID-19) test six days prior to implant procedure Anatomical: Inability to clearly visualize target implantation site Tortuous target implantation site Inadequate inflow and/or outflow to the target region Procedural: Inability to gain access to the access site vein Untreated focal or diffuse stenosis

Sites / Locations

  • Angiosur S.A.S.Recruiting
  • Clínica de La Costa S.A.S.Recruiting
  • Fundacion Oftalmologica De SantanderRecruiting

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Cook® Venous Valve System

Arm Description

Outcomes

Primary Outcome Measures

Freedom from major adverse events in the first 30 days
The primary safety endpoint is freedom from major adverse events (MAE) in the first 30 days, where MAE is defined as: death, clinically-driven reintervention, bleeding requiring transfusion, flow limiting dissection of the target vessel, or clinically significant deep vein thrombosis (DVT), pulmonary embolism, or device migration.

Secondary Outcome Measures

Freedom from MAE at three months, six months, and 12 months
The secondary safety endpoint is freedom from MAE at three months, six months, and 12 months.

Full Information

First Posted
May 15, 2023
Last Updated
May 29, 2023
Sponsor
MED Institute Inc.
search

1. Study Identification

Unique Protocol Identification Number
NCT05883943
Brief Title
Cook Venous Valve System for Treatment of Chronic Venous Insufficiency
Official Title
First-in-Human Early Feasibility Clinical Evaluation of Safety, Efficacy and Utility of the Cook® Venous Valve System for Treatment of Chronic Venous Insufficiency
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Recruiting
Study Start Date
April 24, 2023 (Actual)
Primary Completion Date
August 2024 (Anticipated)
Study Completion Date
January 2029 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
MED Institute Inc.

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
Yes

5. Study Description

Brief Summary
The purpose of this study is to learn about the safety, efficacy and utility of a medical device called the Cook® Venous Valve System. This device, percutaneously placed in the leg, is meant to help the blood flow correctly through the veins in the leg.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Venous Insufficiency of Leg

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
15 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Cook® Venous Valve System
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Cook® Venous Valve System
Intervention Description
The Cook® Venous Valve is a permanent prosthetic, bicuspid, one-way flow valve designed to be percutaneously implanted into the peripheral deep venous system. The Cook® Venous Valve Delivery System is used to percutaneously deliver the Cook® Venous Valve into the deep venous system.
Primary Outcome Measure Information:
Title
Freedom from major adverse events in the first 30 days
Description
The primary safety endpoint is freedom from major adverse events (MAE) in the first 30 days, where MAE is defined as: death, clinically-driven reintervention, bleeding requiring transfusion, flow limiting dissection of the target vessel, or clinically significant deep vein thrombosis (DVT), pulmonary embolism, or device migration.
Time Frame
30 days after enrollment
Secondary Outcome Measure Information:
Title
Freedom from MAE at three months, six months, and 12 months
Description
The secondary safety endpoint is freedom from MAE at three months, six months, and 12 months.
Time Frame
Three months, six months, and 12 months after enrollment

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Limited inclusion criteria: Documented symptomatic deep venous reflux in one limb Deep venous reflux in the region of interest Limited exclusion criteria: General: Age < 18 years BMI ≥ 40 Cultural objections to porcine materials Unwillingness or inability to comply with the follow-up Unwillingness to provide study data for duration of study Simultaneous participation in another device or drug study Inability or refusal to give informed consent Medical: Pregnant, or planning to become pregnant Diagnosis of terminal illness with life expectancy less than 12 months Complete symptom resolution with compliant compression therapy for three months Untreated superficial venous disease Medical interventions including any of the following: planned procedure of any leg, vascular intervention or major surgery within the last three months, implanted inferior vena cava filter Medical history of any of the following: anticoagulation treatment for pulmonary embolism (within the last six months or ongoing), insulin dependent diabetes, chronic obstructive pulmonary disease, renal dysfunction requiring dialysis, leg amputation, bleeding diathesis, untreated or unresolved systemic infection or local infection, active malignancy except non-melanoma skin cancer, other acute or chronic medical condition that may cause noncompliance with the protocol or confound the study results, documented history of significant untreated stenosis within the arterial system Positive coronavirus (COVID-19) test six days prior to implant procedure Anatomical: Inability to clearly visualize target implantation site Tortuous target implantation site Inadequate inflow and/or outflow to the target region Procedural: Inability to gain access to the access site vein Untreated focal or diffuse stenosis
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Lori Nolte, PhD
Phone
+1 855-463-1633
Email
lnolte@medinstitute.com
Facility Information:
Facility Name
Angiosur S.A.S.
City
Antioquia
Country
Colombia
Individual Site Status
Recruiting
Facility Name
Clínica de La Costa S.A.S.
City
Barranquilla
Country
Colombia
Individual Site Status
Recruiting
Facility Name
Fundacion Oftalmologica De Santander
City
Santander
Country
Colombia
Individual Site Status
Recruiting

12. IPD Sharing Statement

Learn more about this trial

Cook Venous Valve System for Treatment of Chronic Venous Insufficiency

We'll reach out to this number within 24 hrs